Trouble reading this e-mail ? View it Online
For prompt delivery, please add to your safe senders list. Vol No.10; Issue 03; Mar 2017
Pharmaceutical Insider - Monthly e-Newsletter
Global Pharmaceutical Technology is the leading pharma title in Online, digital versions serving the information needs of key executives from the world's leading pharmaceutical companies. This is a leading resource guide for Pharmaceutical Events, important Issues and Trends, News, Press Releases shaping the future of the pharmaceutical industry across the world.
Advances in Cellular Therapy
Interested in PR Distribution
Cystic Fibrosis – Opportunity Analysis and Forecasts to 2025
Date: APR 2016 — Single User License : $10,995 | Site License: $21,990 | Global License: $32,985
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which codes for the CFTR protein. As a multisystem condition, CF patients show great heterogeneity in presenting clinical symptoms..etc,
Read More and Get a Sample before Purchase the Report


Press Releases
Events & Exhibitions
Industry Reports
EAA & Clinical Immunology
17th — 21st Jun 2017

European Academy of Allergy & Clinical Immunology The EAACI Congress 2017 offers a unique opportunity to learn about new discoveries and exchange experience with professionals in the field of allergy and clinical immunology.

Venue : Messuaukio 1, Helsinki, Finland
13th Annual Meeting of ISMPP
01st — 03rd May 2017

13th Annual Meeting of ISMPPISMPP has implemented a certification program that offers medical publication professionals an opportunity to earn the recently established Certified Medical Publication..

Venue : National Harbor, Maryland, U.S.
Organization : ISMPP

Back to Top
To publicize your events on Global Pharmaceutical Technology — write to Kevin Paul
more Pharmaceutical industry's current or upcoming events/conferences

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology
— by Selvita

Selvita Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today that both companies have entered into a global license agreement for SEL24, a dual PIM/FLT3 inhibitor currently in Phase I/II trials in acute myeloid leukemia (AML) patients.

Read More

Cellectis to Present at the Conference of the American Association for Cancer Research
— by Cellectis

CellectisCellectis has focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced that data on its gene-edited allogeneic CAR T-cells will be presented.

Read More

Back to Top Peak Biotech A/S
22 rue Lavoisier Nanterre, Cedex - 92022 France

Peak Biotech A/SPeak Biotech A/S is company with focus on pilot- and process scale customized chromatography equipment for the Pharmaceutical and Biotech industry and.etc.,
Read More
PR Distribution
Stay Informed . . .

Pharmaceutical Magazine Publicize Ask for Print Magazine publicizing
Reach your target audience by publicizing in GPT Print Magazine, Write Us

Pharmaceutical Monthly E-NewsletterGet global reach
by publicizing in Website, e-Newsletter / e-Mailer or E-Book Write Us

Back to Top
Other e-Newsletter Titles

Construction Tools

Education  Technology

Healthcare Technology

Automotive Technology

Subscribe Today !
Give your Feed Back about this issue of Pharmaceutical Insider - Monthly e-Newsletter Go TO Top
Interested in Publicizing | Media Kit | Forward to a Friend
A B2B Product of :
This email was sent to you — You are receiving this email because you have either registered for a newsletter on Global Pharmaceutical Technology or our Partner portals.

If don't like to receive our emails, please Unsubscribe; To receive further e-mail related Pharmaceutical industry,
(Or) To opt for any other industry's e-newsletter, please Update your profile. | Privacy Policy

© 2007-2017 Global Pharmaceutical Technology. All rights reserved. JMC IT Mahal PVT.LTD.
Reg # 063984. TN # AACCJ2429F — e-Mail:
Pharmaceutical Insider - Monthly e-Newsletter :: Footer Image

RSS Feeds